FR2353550A2 - Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities - Google Patents

Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities

Info

Publication number
FR2353550A2
FR2353550A2 FR7616445A FR7616445A FR2353550A2 FR 2353550 A2 FR2353550 A2 FR 2353550A2 FR 7616445 A FR7616445 A FR 7616445A FR 7616445 A FR7616445 A FR 7616445A FR 2353550 A2 FR2353550 A2 FR 2353550A2
Authority
FR
France
Prior art keywords
naphthyridine
oxo
indolo
methyl
antianoxia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7616445A
Other languages
French (fr)
Other versions
FR2353550B2 (en
Inventor
Henry Najer
G Gabor
Istvan Koletar
Regis Dupont
Jean
Pierre
Gaston Lefevre
Don Pierre
Rene
Lucien Giudicelli
Claude Constant Henri Morel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR7616445A priority Critical patent/FR2353550A2/en
Priority to DD7700198314A priority patent/DD129791A5/en
Priority to ES457692A priority patent/ES457692A1/en
Priority to IL51853A priority patent/IL51853A/en
Priority to MT811A priority patent/MTP811B/en
Priority to JP52041904A priority patent/JPS5823877B2/en
Priority to US05/786,557 priority patent/US4190657A/en
Priority to YU00948/77A priority patent/YU94877A/en
Priority to SE7704172A priority patent/SE432932B/en
Priority to CH450777A priority patent/CH622795A5/fr
Priority to DK161377A priority patent/DK143703C/en
Priority to AU24189/77A priority patent/AU506031B2/en
Priority to DE19772716190 priority patent/DE2716190A1/en
Priority to NO77771263A priority patent/NO146777C/en
Priority to CA275,948A priority patent/CA1072960A/en
Priority to MX775626U priority patent/MX5340E/en
Priority to GB15165/77A priority patent/GB1543283A/en
Priority to LU77100A priority patent/LU77100A1/xx
Priority to PT66428A priority patent/PT66428B/en
Priority to AR267179A priority patent/AR214519A1/en
Priority to NL7704004A priority patent/NL7704004A/en
Priority to GR53198A priority patent/GR63658B/en
Priority to NZ183846A priority patent/NZ183846A/en
Priority to IE758/77A priority patent/IE44989B1/en
Priority to SU772470258A priority patent/SU655314A3/en
Priority to FI771159A priority patent/FI63404C/en
Priority to PL19737377A priority patent/PL197373A1/en
Publication of FR2353550A2 publication Critical patent/FR2353550A2/en
Priority to AT656178A priority patent/AT355583B/en
Application granted granted Critical
Publication of FR2353550B2 publication Critical patent/FR2353550B2/fr
Priority to FI803790A priority patent/FI803790L/en
Priority to SE8201181A priority patent/SE8201181L/en
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Naphthyridine derivs. of formula (I), as racemates or optical isomers, and their suitable salts with acids are new. In (I) R1=H, 1-4C alkyl, 2-oxopropyl, 2-hydroxypropyl, 3-oxobutyl, 3-hydroxybutyl, cyclopropyl methyl, benzyl (opt. halogenated esp. by F or Cl), acetyl, cyclopropylcarbonyl, benzoyl or (CH2)nR1. R2=H, halo, CH3 or CH3O. R6=H or COR7. R3=CH3 or C2H5, and R4=OH or H and R5=H, or R3+R4=oxo and R5=H, or R3=CH3 or C2H5 and R4+R5=an additional C-C bond. n=1 or 2. R1=(m)ethoxycarbonyl or CN. R7=OH, 1-4C alkoxy, NH2(opt. substd. by 1 or 2 CH3 or by one cyclopropyl). The following cpds. are excluded: R3+R4=oxo; (a) R1=H=R6 and R2=10-CH3O and (b) R1=R2=R6=H; but when R6=alkoxycarbonyl stereoisomers are included. Dose is 10-100 mg/day. In an example methyl 1,2,3,3a,4,5,-hexahydro-3-methyl-6-oxo-6H-indolo 3,2,1-de 1,5 naphthyridine-4-carboxylate was prepd. fron Nb-methyltryptamine and diethyl alpha-formyl succinate.
FR7616445A 1976-03-11 1976-06-01 Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities Granted FR2353550A2 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
FR7616445A FR2353550A2 (en) 1976-06-01 1976-06-01 Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
DD7700198314A DD129791A5 (en) 1976-04-13 1977-04-07 PROCESS FOR THE PREPARATION OF NAPHTYRIDINE DERIVATIVES
IL51853A IL51853A (en) 1976-04-13 1977-04-11 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
MT811A MTP811B (en) 1976-04-13 1977-04-11 Indolo (3,2,1-de)(1.5) naphthyzidine derivatives
JP52041904A JPS5823877B2 (en) 1976-04-13 1977-04-11 Naphthyridine derivatives and their production method
US05/786,557 US4190657A (en) 1976-03-11 1977-04-11 Naphthyridine derivatives
YU00948/77A YU94877A (en) 1976-04-13 1977-04-11 Process for obtaining naphthiridine derivatives
ES457692A ES457692A1 (en) 1976-04-13 1977-04-11 Procedure for preparing naftiridine derivatives. (Machine-translation by Google Translate, not legally binding)
MX775626U MX5340E (en) 1976-04-13 1977-04-12 PROCEDURE FOR PREPARING HEXAHYDRO DERIVATIVES 1,2,3,3A.4,5-OXO-6-6H-INDOLO (3,2,1-DE) NAFTIRIDINE
DK161377A DK143703C (en) 1976-04-13 1977-04-12 ANALOGY PROCEDURE FOR PREPARING 1,2,3,3A, 4,5-HEXAHYDRO-6-OXO-6H-INDOLO (3,2,1-DE) = (1,5) NAPHTHYRIDINE DERIVATIVES OR ACID ADDITION SALTS THEREOF
AU24189/77A AU506031B2 (en) 1976-04-13 1977-04-12 Indolo(3, 2, 1-de) (1, 5) naphthyrudune derivatives
DE19772716190 DE2716190A1 (en) 1976-04-13 1977-04-12 NAPHTYRIDE DERIVATIVES, A PROCESS FOR THEIR MANUFACTURING, AND THESE COMPOUNDS AS MEDICINAL PRODUCTS CONTAINING ACTIVE SUBSTANCES
NO77771263A NO146777C (en) 1976-04-13 1977-04-12 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 6H-INDOLO (3,2,1-DE) - (1,5) -NAPHYRIDINE INGREDIATES
CA275,948A CA1072960A (en) 1976-04-13 1977-04-12 Indolo (3,2,1-de) (1,5) naphthyridine derivatives
SE7704172A SE432932B (en) 1976-04-13 1977-04-12 ANALOGY PROCEDURE FOR PREPARING DERIVATIVES OF 1,2,3,3A-TETRAHYDRO-INDOLO / 3,2,1-DE / / 1,5 / NAFTYRIDINE
GB15165/77A GB1543283A (en) 1976-04-13 1977-04-12 Indolo-(3,2,1-de)(1,5)naphthyridine derivatives
LU77100A LU77100A1 (en) 1976-04-13 1977-04-12
PT66428A PT66428B (en) 1976-04-13 1977-04-12 PROCESS FOR THE PREPARATION OF NEW NAPHTHYRIDINE DERIVATIVES
AR267179A AR214519A1 (en) 1976-04-13 1977-04-12 PROCEDURE TO OBTAIN TETRAHYDRO-1,2,3,3A-INDOL- (3,2,1-DE) NAPHTHYRIDINE
CH450777A CH622795A5 (en) 1976-04-13 1977-04-12
PL19737377A PL197373A1 (en) 1976-04-13 1977-04-13 METHOD OF MAKING NEW DERIVATIVES 1,2,3,3A-TETRAHYDROGENINDOLO / 3,2,1 // 1,5 / NAPHTHRIDINE
GR53198A GR63658B (en) 1976-04-13 1977-04-13 Process for derivatives preparation of naphyridine
NZ183846A NZ183846A (en) 1976-04-13 1977-04-13 1,2,3,3a,4,5-hexahydro-6h-indolo(3,2,1-de) (1,5)-naphthyridines
IE758/77A IE44989B1 (en) 1976-04-13 1977-04-13 Indolo(3,2,1-d,e)(1,5)naphthyridine derivatives
SU772470258A SU655314A3 (en) 1976-04-13 1977-04-13 Method of obtaining naphthyridine derivatives or their stereoisomers or their salts
FI771159A FI63404C (en) 1976-04-13 1977-04-13 FRONTAL PROTECTION OF ANTANOXIC 1,2,3,3A, 4,5-HEXAHYDRO-6-OXO-6H-INDOLO (3,2,1-DE) (1,5) NAPHTHYRIDINE
NL7704004A NL7704004A (en) 1976-04-13 1977-04-13 Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
AT656178A AT355583B (en) 1976-04-13 1978-09-11 METHOD FOR PRODUCING NEW NAPHTYRIDINE DERIVATIVES IN THE FORM OF ITS RACEMATE OR ITS OPTICAL ISOMERS AND THEIR SALTS
FI803790A FI803790L (en) 1976-04-13 1980-12-05 FREQUENCY REFRIGERATION OF ANTIANOXIC 1,2,3,3A, 4,5-HEXAHYDRO-6-OXO-6H-INDOLO / 3,2,1-DE / / 1,5 / NAPHTHYRIDINE
SE8201181A SE8201181L (en) 1976-04-13 1982-02-25 PROCEDURE FOR PREPARING NEW DERIVATIVES OF 1,2,3,3A-TETRA-HYDRO-INDOLO- (3,2,1-DE) (1,5) NAFTYRIDINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7616445A FR2353550A2 (en) 1976-06-01 1976-06-01 Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities

Publications (2)

Publication Number Publication Date
FR2353550A2 true FR2353550A2 (en) 1977-12-30
FR2353550B2 FR2353550B2 (en) 1979-01-12

Family

ID=9173823

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7616445A Granted FR2353550A2 (en) 1976-03-11 1976-06-01 Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities

Country Status (1)

Country Link
FR (1) FR2353550A2 (en)

Also Published As

Publication number Publication date
FR2353550B2 (en) 1979-01-12

Similar Documents

Publication Publication Date Title
IL114690A (en) Antimigraine oxazolidinone substituted indole derivatives
ES356976A1 (en) 1h - imidazo(4,5-b)pyrazin - 2 - one and processes for their preparation
FR2358146A1 (en) Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
FR2374905A2 (en) Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
FR2383182A2 (en) Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
FR2383181A2 (en) Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
FR2368955A2 (en) Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
FR2353550A2 (en) Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
NL7704004A (en) Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
IT1096815B (en) Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
ES396451A1 (en) 2-amino-4,5,7,8-tetrahydro-6h-thiazolo-or oxazolo(5,4-d) - azepines - as hypotensive, antiphlogistic, sedative and bechic agents
ES2100397T3 (en) ESPIRO (5.5) UNDECANS 3,9-DISUBSTITUTED ACTIVE ON THE CARDIOVASCULAR SYSTEM, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THE SAME.
GB1098835A (en) Spiro-oxazolidinones, spiro-oxazines, their process of preparation and therapeutic compositions containing said derivatives
NZ224956A (en) Benzo-thieno-thiazine derivatives, pharmaceuticals and intermediates
FR2068402A1 (en) Medicaments contg 2-phenyl-benzimidazoles
FR2161051A2 (en) Tricyclic dihydroquinazolinone derivs - with bronchodilating or hypotensive activity
NL7811882A (en) 2-(ortho-aminophenethyl) piperidines - as antiarrhythmic, antiserotonin agents
FR2166101A1 (en) 1,4-di (morpholino,piperidino or pyrrolidino)-7-substd - -pyrido (3,4-d)-pyridazines - as diuretics
FR2254549A1 (en) 3-(Substd. phenyl)-2-chloropropionic acid derivs - hypolipidaemics and hypoglycaemics
GB982252A (en) New cephalosporin compounds and method for preparing same
ES394969A1 (en) 5-(2-amino-alkoxy-phenoxy-methyl)-3-alkyl-isoxazoles - useful as hypotensives and sedatives
FR2042309A1 (en) New heterocyclic antiphlogistic compounds
GB1218590A (en) N-substituted piperidine spiro compounds
FR2378004A2 (en) (N)-arylsulphonyl-L-arginine amide derivs. - useful as antithrombotic agents of low toxicity
ES394968A1 (en) 5-(2-amino-alkoxy-phenoxy-methyl)-3-alkyl-isoxazoles - useful as hypotensives and sedatives